Efficacy and Safety of Lenalidomide Monotherapy for Relapsed/Refractory Diffuse Large B Cell Lymphoma: Systematic Review and Meta-Analysis.

Li, Jia; Zhou, Jianpeng; Guo, Wei; Wang, Xingtong; Zhao, Yangzhi; Bai, Ou

Li, Jia; Zhou, Jianpeng; Guo, Wei; Wang, Xingtong; Zhao, Yangzhi; Bai, Ou.

Afiliación

Li J; Department of Hematology, The First Hospital of Jilin University, Changchun, China.
Zhou J; Department of Hepatological Surgery, The First Hospital of Jilin University, Changchun, China.
Guo W; Department of Hematology, The First Hospital of Jilin University, Changchun, China.
Wang X; Department of Hematology, The First Hospital of Jilin University, Changchun, China.
Zhao Y; Department of Hematology, The First Hospital of Jilin University, Changchun, China.
Bai O; Department of Hematology, The First Hospital of Jilin University, Changchun, China.

Front Oncol ; 11: 756728, 2021.

Article en En | MEDLINE | ID: mdl-34926259

Palabras clave

diffuse large B-cell lymphoma; lenalidomide; meta-analysis; monotherapy; systematic review; treatment outcome

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 3_ND Problema de salud: 3_diarrhea Tipo de estudio: Systematic_reviews Idioma: En Revista: Front Oncol Año: 2021 Tipo del documento: Article País de afiliación: China

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google